KUALA LUMPU: Automotive player Sime Darby Motors Malaysia (SDM) and global biopharmaceutical company AstraZeneca have teamed up to accelerate the adoption of electric vehicles (EVs).
In a joint statement, the parties said the signing of the Memorandum of Understanding (MoU) marked AstraZeneca’s commitment to transition to an EV fleet in line with its Ambition Zero Carbon programme to reduce carbon emission and address climate change.
The partnership between a biopharmaceutical company and SDM is the first in Malaysia and would entail the provision of corporate rates to AstraZeneca’s employees to own an EV, in particular, BMW, BYD and Hyundai.
SDM said it is focusing on creating a more energy-efficient product portfolio, and is expanding its EV line-up, charging network, as well as skilled workforce for EV retail and aftersales services.
Keyword: Sime Darby Motors, Astrazeneca team up to accelerate EV adoption